Showing 1031-1040 of 1614 results for "".
- Market Scope: Global PC-IOL Demand Rises Modestly, Soars in a Few Countrieshttps://modernod.com/news/market-scope-global-pc-iol-demand-rises-modestly-soars-in-a-few-countries/2480888/Presbyopia-correcting IOLs experienced steady global growth in 2021 and record-breaking growth in a handful of countries, according to a Market Scope re
- Market Scope: Robotic Vitrectomy Debate Still Rages for Retina Surgeonshttps://modernod.com/news/market-scope-robotic-vitrectomy-debate-still-rages-for-retina-surgeons/2480773/The future of robotic vitrectomy continues to be top of mind for retina surgeons, with panelists at nearly every major retina meeting in 2021 debating the topic—and without reaching co
- Heru Appoints Former Amazon Executive Brandon Barber as Chief Marketing Officerhttps://modernod.com/news/heru-appoints-former-amazon-executive-brandon-barber-as-chief-marketing-officer/2480679/Heru has announced that veteran tech industry executive Brandon Barber has joined the company as Chief Marketing Officer, effective February 14. “Brandon is a proven strategic and tactical leader whose depth of experience will greatly benefit Heru as we continue to red
- Lensbox Launches 480+ First-to-Market Eye Care Patient Experience Centers in the US and Canadahttps://modernod.com/news/lensbox-launches-480-first-to-market-eyecare-patient-experience-centers-in-the-us-and-canada/2480652/Lensbox has announced the launch of 480+ Lensbox EyeDocs. The "bricks and clicks technology" features fully automated patient experience centers that integrate with the Lensbox first-to-market app, tying in tele-optometry, e-commerce, and point-of-sale technology for
- New Post-Marketing Safety Analysis Shows Rate of Hearing-Related Events Associated with Tepezza Comparable with Clinical Trial Observationshttps://modernod.com/news/new-post-marketing-safety-analysis-shows-rate-of-hearing-related-events-associated-with-tepezza-comparable-with-clinical-trial-observations/2480647/Horizon Therapeutics announced results from a new post-marketing safety analysis of hearing events associated with Tepezza for the treatment of Thyroid Eye Disease (TED). These findings, along with data on the sustainability of response to Tepezza, were presented at the 48th
- GlobalData: Glaucoma Market to Grow to $3.5 Billion by 2030, Driven by Launch of New Pipeline Productshttps://modernod.com/news/globaldata-glaucoma-market-to-grow-to-35-billion-by-2030-driven-by-launch-of-new-pipeline-products/2480609/Steady growth is expected for the glaucoma market across the seven major markets* from $2.8 billion in 2020 to $3.5 billion in 2030, at a compound annual growth rate (CAGR) of 2.0%, according to GlobalData. According to the leading data and analytics company’s latest re
- Spherix Global Insights Introduces Ophthalmology to Suite of Independent Market Research and Intelligence Serviceshttps://modernod.com/news/spherix-global-insights-introduces-ophthalmology-to-suite-of-independent-market-research-and-intelligence-services/2480450/Spherix Global Insights, a market research firm providing independent coverage of select specialty markets, officially cut the ribbon on their ophthalmology franchise. Spherix derives actionable insights from its frequent, commercially-focused, primary market research, which i
- Market Scope: Factors Driving Retinal Pharma Pipelines are Injection Interval, Safety, and Pricehttps://modernod.com/news/market-scope-factors-driving-retinal-pharma-pipelines-are-injection-interval-safety-and-price/2480338/Longer injection intervals without gene therapy might be the theme for retinal pharmaceuticals in 2021, thanks to subsidiaries of the Roche Group filing marketing ap
- Orasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Planhttps://modernod.com/news/orasis-pharmaceuticals-appoints-julie-speed-as-senior-vice-president-head-of-strategy-and-marketing-to-lead-commercial-growth-plan/2480321/Orasis Pharmaceuticals announced the appointment of Julie Speed as senior vice president (SVP), head of strategy and marketing. Ms. Speed brings over two decades of leadership in eye care and will be responsible for developing the brand strategy and building the marketin
- Glaukos Submits Supplemental Pre-Market Approval Application for iStent Infinitehttps://modernod.com/news/glaukos-submits-supplemental-pre-market-approval-application-for-istent-infinite/2479482/Glaukos announced that it has submitted a supplemental pre-market approval (PMA) application to the FDA for the iStent infinite Trabecular Micro-Bypass System. The iStent infinite is an investigational device designed for use in a standalone procedure to reduce elevated IOP in p